Cargando…
FIV-infected cats respond to short-term rHuG-CSF treatment which results in anti-G-CSF neutralizing antibody production that inactivates drug activity
The hematological and virological effects of recombinant human granulocyte colony-stimulating factor (rHuG-CSF) were evaluated in feline immunodeficiency virus (FIV)-infected cats. Six age-matched, FIV-infected cats used in this cross-over study were injected subcutaneously with 5 μg/kg of rHuG-CSF...
Autores principales: | Phillips, K., Arai, M., Tanabe, T., Raskin, R., Volz, M., Uhl, E.W., Yamamoto, J.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112681/ https://www.ncbi.nlm.nih.gov/pubmed/16098604 http://dx.doi.org/10.1016/j.vetimm.2005.06.010 |
Ejemplares similares
-
Induction of T-cell mitogenic unresponsiveness by recombinant human granulocyte colony-stimulating factor (rHuG-CSF)
por: Rutella, S, et al.
Publicado: (2000) -
FIV vaccine development and its importance to veterinary and human medicine: a review: FIV vaccine 2002 update and review
por: Uhl, E.W, et al.
Publicado: (2002) -
G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990) -
Transient thrombocytopenia in a cat following G‐CSF treatment
por: Kim, Kyeong‐Bo, et al.
Publicado: (2021) -
Use of Filgrastim (r-metHuG-CSF) in Human Immunodeficiency Virus Infection
por: Hemmige, Vagish, et al.
Publicado: (2011)